FR2327793B1 - - Google Patents

Info

Publication number
FR2327793B1
FR2327793B1 FR7631196A FR7631196A FR2327793B1 FR 2327793 B1 FR2327793 B1 FR 2327793B1 FR 7631196 A FR7631196 A FR 7631196A FR 7631196 A FR7631196 A FR 7631196A FR 2327793 B1 FR2327793 B1 FR 2327793B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7631196A
Other versions
FR2327793A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Morinaga Milk Industry Co Ltd
Original Assignee
Morinaga Milk Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morinaga Milk Industry Co Ltd filed Critical Morinaga Milk Industry Co Ltd
Publication of FR2327793A1 publication Critical patent/FR2327793A1/fr
Application granted granted Critical
Publication of FR2327793B1 publication Critical patent/FR2327793B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
FR7631196A 1975-10-17 1976-10-15 Procede de preparation d'un agent de guerison de la leucemie myelogene et nouveau produit ainsi obtenu Granted FR2327793A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP50124435A JPS5251009A (en) 1975-10-17 1975-10-17 Method of producing drug for treating marrow leukemia

Publications (2)

Publication Number Publication Date
FR2327793A1 FR2327793A1 (fr) 1977-05-13
FR2327793B1 true FR2327793B1 (fr) 1980-04-11

Family

ID=14885408

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7631196A Granted FR2327793A1 (fr) 1975-10-17 1976-10-15 Procede de preparation d'un agent de guerison de la leucemie myelogene et nouveau produit ainsi obtenu

Country Status (5)

Country Link
US (1) US4100022A (fr)
JP (1) JPS5251009A (fr)
DE (1) DE2645993A1 (fr)
FR (1) FR2327793A1 (fr)
GB (1) GB1535063A (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4198479A (en) * 1979-03-30 1980-04-15 Merck & Co., Inc. Replacement of animal serum proteins by human albumin for growth and interferon production by Namalva cells
JPS56135420A (en) * 1980-03-26 1981-10-22 Fumiaki Taguchi Suppressive substance of virus and its preparation
US4599305A (en) * 1984-07-16 1986-07-08 The Regents Of The University Of California Method and composition for detection of human chronic myelogenous leukemia
KR100350169B1 (ko) * 1992-06-04 2004-05-20 머크 앤드 캄파니 인코포레이티드 약독화된바리셀라조스터바이러스백신의제조방법,및이를위한세포의단층배양방법및조성물
US6152142A (en) 1997-02-28 2000-11-28 Tseng; Scheffer C. G. Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries
CN103356708B (zh) * 2005-03-31 2016-01-20 斯丹姆涅恩有限公司 制备用以预防手术后疝形成的药物的方法
US8182841B2 (en) 2005-09-27 2012-05-22 Tissue Tech, Inc. Amniotic membrane preparations and purified compositions and anti-inflammation methods
US8187639B2 (en) 2005-09-27 2012-05-29 Tissue Tech, Inc. Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
US20120301444A1 (en) * 2007-09-27 2012-11-29 Clarke Diana L Amnion-derived cell compositions, methods of making and uses thereof
US9682044B2 (en) 2011-06-10 2017-06-20 Tissuetech, Inc. Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof
WO2016138025A2 (fr) 2015-02-23 2016-09-01 Tissuetech, Inc. Appareils et méthodes de traitement de maladies et de troubles ophtalmiques
TW201733600A (zh) 2016-01-29 2017-10-01 帝聖工業公司 胎兒扶持組織物及使用方法
KR102386411B1 (ko) 2020-06-03 2022-04-15 주식회사 대동 칼날 미세 조절이 가능한 예취장치

Also Published As

Publication number Publication date
US4100022A (en) 1978-07-11
DE2645993A1 (de) 1977-04-28
JPS5251009A (en) 1977-04-23
DE2645993C2 (fr) 1988-06-23
FR2327793A1 (fr) 1977-05-13
GB1535063A (en) 1978-12-06
JPS5330781B2 (fr) 1978-08-29

Similar Documents

Publication Publication Date Title
JPS5330781B2 (fr)
CH602827A5 (fr)
CH592251A5 (fr)
BG22160A1 (fr)
BG22651A1 (fr)
BG22886A1 (fr)
BG23133A1 (fr)
CH580195A5 (fr)
CH581412A5 (fr)
CH582505A5 (fr)
CH583815A (fr)
CH583885A5 (fr)
CH584577A5 (fr)
CH586393A5 (fr)
CH589120A5 (fr)
CH589559A5 (fr)
CH591272A5 (fr)
CH591719B5 (fr)
CH602241A5 (fr)
CH593359A5 (fr)
CH594166A5 (fr)
CH594456A5 (fr)
CH595193A5 (fr)
CH595825A5 (fr)
CH595945A5 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse
AR Application made for restoration
BR Restoration of rights